Mitsubishi UFJ Asset Management (UK) Ltd.
Position in PVLA — Palvella Therapeutics, Inc.
CIK 1694895
LONDON, X0
Position in PVLA
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$840,510
New position
Shares Held
5,500
first reported quarter
Ownership
0.038%
of shares outstanding
% of Portfolio
0.49%
of 13F equity value
Holder Rank
#5
of 23 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026Mitsubishi UFJ Asset Management (UK) Ltd. holds $4,092,972 across 7 Biotechnology names. PVLA ranks #3 (20.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,000 | $993,460 | |
| 2 | IMNM |
Immunome Inc.
|
45,000 | $953,550 | |
| 3 | PVLA |
Palvella Therapeutics, Inc.
This page
|
5,500 | $840,510 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
2,900 | $543,112 | |
| 5 | BHVN |
Biohaven Ltd.
|
30,000 | $446,400 | |
| 6 | HELP |
Cybin Inc.
|
31,000 | $204,910 | |
| 7 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
1,000 | $111,030 |
All Filings in PVLA
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $840,510 | 5,500 | Shares | Defined | 2026-07-28 | |
| No filing history on record for this holder in this stock. | ||||||